Halneuron for Neuropathy
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the drug Halneuron for treating neuropathy?
Research shows that topical doxepin cream, a component of Halneuron, was effective in treating severe peripheral neuropathy in a pediatric patient. Additionally, similar treatments like oxcarbazepine and carbamazepine have been shown to alleviate neuropathic pain, suggesting potential effectiveness for Halneuron.12345
What is the purpose of this trial?
A randomized study to determine safety and efficacy of single subcutaneous (SC) administration of HAL treatment in patients with CINP.
Eligibility Criteria
This trial is for adults over 18 who have neuropathic pain due to chemotherapy with taxanes or platinum, and whose cancer isn't currently getting worse. It's not suitable for those who don't meet these specific conditions.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a single subcutaneous administration of Halneuron or placebo
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Halneuron
Find a Clinic Near You
Who Is Running the Clinical Trial?
Dogwood Therapeutics Inc.
Lead Sponsor